Sale of 16,666 shares at $9.4079 per share.
Reporting Person Hecht Beth · Officer Title See Remarks · Transaction Code S
Traded Oct 1, 2026 · Disclosed Oct 2, 2026
Source: SEC Form 4 · 0001867096-26-000084 · filed 2026-10-02 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Xeris Biopharma Holdings, Inc. (XERS)." Disclosed 2026-10-02. https://desqlong.com/cards/0001867096-26-000084-1 (retrieved 2026-10-03).